Health Press Release – Weekly Newsletter for November 1-8, 2010

General Manifolds LLC Announces Issuance of US Patent in Computational Neuroscience

CARLSBAD, California, November 1, 2010 – General Manifolds LLC, a technology company focused on fundamental
cognitive algorithms, announced today that the United States Patent and
Trademark Office has issued US Patent 7,805,386 covering a computational
system and method for simulating functions within the cerebral cortex of the
human brain. This ground-breaking technology is relevant to a broad range … Read : General Manifolds LLC Announces Issuance of US Patent in Computational Neuroscience.

Helsinn Announces License Agreement With Specialised Therapeutics for Palonosetron in Australia

Leading Anti-Nausea Drug Available to Australian and New Zealand Cancer Patients

LUGANO, Switzerland and MELBOURNE, Australia, November 1, 2010 – Australians can now access a new drug to prevent acute (and delayed
phase) nausea and vomiting which may occur in cancer patients undergoing
chemotherapy(1). This follows an agreement between the Swiss pharmaceutical
group Helsinn and Specialised Therapeutics Australia … Read this article on Gaea Times at : Helsinn Announces License Agreement With Specialised Therapeutics for Palonosetron in Australia.

Anemia – Pipeline Assessment and Market Forecasts to 2017 Now Available Sandler Research

DALLAS, November 1, 2010 – Sandler Research announces it will carry Anemia – Pipeline Assessment and
Market Forecasts to 2017 Research Report in its store.

Browse the complete Report on:
www.sandlerresearch.org/reports/37162-anemia-pipeline-assessment-and-m
arket-forecasts-to-2017.html
Browse All Food and Beverages Reports:
www.sandlerresearch.org/market-research/pharmaceuticals/
Search More Then 20000 Market Research Reports at
www.sandlerresearch.org/
…. Source  : Anemia – Pipeline Assessment and Market Forecasts to 2017 Now Available Sandler Research.

Peripheral Arterial Disease (PAD) – Pipeline Assessment and Market Forecasts to 2017 Now Available at ReportsandReports

DALLAS, November 1, 2010 – ReportsandReports announces it will carry Peripheral Arterial Disease
(PAD) – Pipeline Assessment and Market Forecasts to 2017 Research Report in
its store.

Browse the complete Report on:
www.reportsnreports.com/Reports/37204-peripheral-arterial-disease-pad-
pipeline-assessment-and-marke.html
Browse All Manufacturing & Construction Reports:
www.reportsnreports.com/market-research/pharmaceuticals/
Browse All GlobalData Research Reports at
www.reportsnreports.com/publishers/globaldata/
… Read this article on Gaea Times at : Peripheral Arterial Disease (PAD) – Pipeline Assessment and Market Forecasts to 2017 Now Available at ReportsandReports.

Installation of a Second CyberKnife(R) Robotic Radiosurgery System in Vicenza Hospital

Vicenza, the First Facility to Have Offered CyberKnife Radiosurgery in Europe, Increases its Capacity to Treat More Cancer Patients with the Installation of a Second System

SUNNYVALE, California, November 1, 2010 – Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of
radiosurgery, announced today that Vicenza Hospital, Ospedale Civile San
Bortolo in Italy, has become [..] Read the original article: here.

Health Robotics Continues Worldwide Consolidation by Entering the Norwegian Market With Beckman Automation

BOZEN, Sud-Tirol, Italy, November 1, 2010 – Health Robotics today announced that it recently signed an exclusive
distribution agreement in Norway for its CytoCare, i.v.STATION, and i.v.SOFT
world-leading technologies with local Pharmacy Technology leader Beckman
Automation AS. This partnership represents Health Robotics' market entry into
its 12th new country in 2010, persisting on its worldwide quest to
pervasively provide … Read more »»».

Delivering on Jobs, Prosperity, Schools and Hospitals but “More to do” Says RB

LUSAKA, Zambia, November 1, 2010 – Tomorrow, 2 November 2010, marks two years since His Excellency Mr Rupiah
Banda became President of Zambia.

President Banda succeeded the late President Levy Mwanawasa in November
2008, promising to build on his predecessor's achievements by campaigning on
the themes of 'Continuity, Good Governance and Prosperity for All.'
…. Original article on Gaea Times at  : Delivering on Jobs, Prosperity, Schools and Hospitals but "More to do" Says RB.

Genesis, The Biomimetic Implant System(TM), Receives Regulatory Clearance

A Major Advance in Aesthetic Implant Dentistry Launches in the U.S.
BURLINGTON, Massachusetts, November 1, 2010 – Keystone Dental, Inc. today announced U.S. regulatory clearance of
Genesis, The Biomimetic Implant System. The Genesis System represents a major
advance in implant dentistry through its biomimetic design – a design
inspired by nature. The unique benefits of the Genesis System … Read this article on Gaea Times at : Genesis, The Biomimetic Implant System(TM), Receives Regulatory Clearance.

European Food Makers in Race to Softer Health Claims

Innova Market Insights (HiE, Madrid, Stand: R84)
DUIVEN, The Netherlands, November 2, 2010 – New product development in the European supplements sector is slowing
down and food product manufacturers are switching to more general claims in
the healthy foods space, as uncertainty around EFSA health claims
(www.innovadatabase.com/home/index.rails) continues.

Innova Market Insights tracked 384 new supplement … Original article on : European Food Makers in Race to Softer Health Claims.

Ingenuity Systems and Geospiza Collaborate to Create Seamless Next-Generation Sequencing Workflow

REDWOOD CITY, California, November 3, 2010 – Ingenuity(R) Systems, a leading provider of information solutions for
life science researchers, and Geospiza, Inc., the market leading developer of
laboratory management and genetic analysis software, today announced a
collaboration to enable a seamless next-generation sequencing analysis
workflow. The companies will integrate their software products, GeneSifter(R)
and IPA(R), to enable researchers to … Read : Ingenuity Systems and Geospiza Collaborate to Create Seamless Next-Generation Sequencing Workflow.

Cellonis’ Cell Treatment for Glioma May Prevent Tumor Recurrence and Improve Quality of Life Significantly

BEIJING, November 3, 2010 – "For brain cancer patients after surgery, the combined DC-CIK and stem
cell therapy from Cellonis Biotechnologies can be a very effective method in
preventing cancer recurrence," says renowned cancer doctor Dr. Dinggang Li.
"This is a new hope for cancer patients."

The unique therapy combines the latest stem cell …. Source article on Gaea Times at  : Cellonis' Cell Treatment for Glioma May Prevent Tumor Recurrence and Improve Quality of Life Significantly.

New Report Pet Insurance in North America, 4th Edition Now Available at Sandler Research

DALLAS, November 3, 2010 – Sandler Research announces it will carry Pet Insurance in North
America, 4th Edition Research Report in its store.

Browse the complete Report on:
www.sandlerresearch.org/reports/38160-pet-insurance-in-north-america-
4th-edition.html
Browse All Food and Beverages Reports:
www.sandlerresearch.org/market-research/banking-services/
Search More Than 20000 Market Research Reports at
www.sandlerresearch.org/
Browse …. Read the original article  : here.

MarketsandMarkets: Global Thin Film Photovoltaics (PV) Market Worth $19,422 Million in 2015

DALLAS, November 3, 2010 – Low cost and optimum efficiency of thin film PV cells is driving the
growth of the thin film PV in overall photovoltaic market. The global thin
film photovoltaic market (
www.marketsandmarkets.com/Market-Reports/thin-film-pv-31.html) is
expected to grow from $3,406 million in 2009 to $19,422 million in 2015, at
an estimated CAGR of 32.2% from 2010 to …. Source article  : MarketsandMarkets: Global Thin Film Photovoltaics (PV) Market Worth $19,422 Million in 2015.

D-Pharm Ltd Appoints CRO for Clinical Development of DP-b99 in China

REHOVOT, Israel, November 3, 2010 – D-Pharm (TASE: DPRM) announced today the appointment of Hangzhou
Tigermed Consulting Co., Ltd as the contract research organization to manage
the regulatory filings and conduct the clinical trials of DP-b99, in China.
The agreement was signed together with Wanbang Biopharmaceuticals, as part of
the D-Pharm – Wanbang co-development program for DP-b99 in …. Source article  : D-Pharm Ltd Appoints CRO for Clinical Development of DP-b99 in China.

New Report European Vaccine Markets Now Available at ReportsnReports

DALLAS, November 3, 2010 – ReportsandReports announces it will carry European Vaccine Markets
Research Report in its store.

Browse the complete Report on:
www.reportsnreports.com/Reports/38156-european-vaccine-markets.html
Browse All Manufacturing & Construction Reports:
www.reportsnreports.com/market-research/medical-devices/
Browse All Kalorama Research Reports at
www.reportsnreports.com/publishers/kalorama-information/
The European vaccines market has demonstrated growth even …. Read the original article  : here.

IDEV Technologies Announces FDA 510(k) Clearance for SUPERA VERITAS(TM)

New SUPERA(R) Delivery System Improves Procedure Predictability and Stent Performance

WEBSTER, Texas, November 3, 2010 – IDEV Technologies, Incorporated (IDEV), an innovative leader in the
development and commercialization of minimally invasive medical technologies,
today announced U.S. Food and Drug Administration (FDA) 510(k) clearance to
market the SUPERA VERITAS Transhepatic Biliary System.
SUPERA VERITAS is the …. Source article on Gaea Times at  : IDEV Technologies Announces FDA 510(k) Clearance for SUPERA VERITAS(TM).

Thrifty White Drug Stores Chooses Gold Standard/Elsevier to Improve its Drug Dispensing System

Pharmacists and Patients at Employee-Owned Retailer Will Use Alchemy for Accurate, Timely Medication Knowledge

TAMPA, Florida, November 3, 2010 – Gold Standard/Elsevier, developer of drug information and medication
management solutions, announced today that Thrifty White Drug Stores, an
employee-owned pharmacy with 88 stores in six states, has licensed Alchemy
(www.goldstandard.com/pages/alchemy.html?epm=1_1) as the new drug
database and decision support solution …. Source article on Gaea Times at  : Thrifty White Drug Stores Chooses Gold Standard/Elsevier to Improve its Drug Dispensing System.

Greener Pastures for Trimega in Manchester

LONDON, November 3, 2010 – Trimega Laboratories is looking to rapidly expand its Local Government
business, having achieved ISO 14001 certification for its Manchester-based
substance abuse testing facilities.

The ISO 14001 standard, which is used by organisations to design and
implement an effective environmental management system, is now often a
pre-requisite for Local Authorities in … Original source on Gaea Times at : Greener Pastures for Trimega in Manchester.

The “Piece of the Mind” Responsible for Peace of Mind

Ground-breaking research could lead to new treatments for anxiety disorders and depression

LONDON, November 3, 2010 – Researchers from King's College London, in partnership with AXA, have
initially identified the neural pathways that control peace of mind in the
human brain. The research project could lead to the development of new
therapies in the treatment of anxiety disorders … Read the original article on Gaea Times at : The "Piece of the Mind" Responsible for Peace of Mind.

Bluestar Silicones Introduces its New Silbione(R) Products for Healthcare at MEDICA 2010 in Dusseldorf

LYON, France, November 4, 2010 – Bluestar Silicones introduces its new Silbione(R) products at MEDICA 2010
in Dusseldorf for Healthcare (17. – 19. November 2010) to showcase its
innovative skin-friendly Silbione(R) range of silicones products

Designed specifically for the global healthcare market, the Silbione(R)
brand of specialty silicones offers high quality and innovative material
solutions … Read the original article on Gaea Times at : Bluestar Silicones Introduces its New Silbione(R) Products for Healthcare at MEDICA 2010 in Dusseldorf.

Interventional Spine(R), Inc. Announces Issuance of Key Patents for the PERPOS(R) PLS System

IRVINE, California, November 4, 2010 – Interventional Spine(R), Inc. today announced that the United States
Patent Office has issued U.S. Patent No. 7,824,429, entitled Method and
Apparatus for Spinal Fixation. This patent includes 43 claims that provide
key patent protection for the Company's percutaneous transfacet-pedicular
compression system for posterior spine fixation sold under the PERPOS(R) PLS
System name and … Original article on : Interventional Spine(R), Inc. Announces Issuance of Key Patents for the PERPOS(R) PLS System.

Able Home Life Announce Unique 12 Month Guarantee

BISHOP'S STORTFORD, England, November 4, 2010 – Able Home Life, the recently launched mobility website, is putting
customer satisfaction above short-term business gain by offering a Total
Satisfaction Guarantee across all 3,500 of its healthcare and lifestyle
products. The 12 month satisfaction guarantee is designed to encourage
customer buying confidence; something that is still under strain due to …. Original article  : Able Home Life Announce Unique 12 Month Guarantee.

Cheetah Medical’s NICOM(R) System for Noninvasive Hemodynamic Monitoring Found to be an Effective Tool for Identification of Acute Heart Failure in the Emergency Department

Cleveland Clinic Researchers Find That NICOM(R) Technology Provides a Quick Noninvasive Tool to Help Diagnose Acute Heart Failure in Patients Presenting to the Emergency Department With Shortness of Breath

TEL AVIV, Israel, November 4, 2010 – A study performed by investigators from the Emergency
Department of the Cleveland Clinic Foundation finds that Cheetah Medical's
NICOM system is … Read more »»».

MedImmune Announces Winners of European Cancer Research Abstract Competition

CAMBRIDGE, England, November 4, 2010 – Today MedImmune announced the winners of its second annual European
research abstract competition which highlights the research of the next
generation of scientific leaders in cancer research. Students and
postdoctoral fellows from across Europe were invited to submit abstracts
describing their research in the field of tumour microenvironments as part of
the competition … Read more : MedImmune Announces Winners of European Cancer Research Abstract Competition.

bioMerieux and Biocartis Sign Strategic Partnership in Molecular Diagnostics

MARCY L'ETOILE, France and LAUSANNE, Switzerland, November 4, 2010 -

– Co-development of Assays and Co-distribution of a Fully Integrated
Molecular Platform due for Launch in 2012

– bioMerieux Gains Exclusive Rights in Microbiology

– bioMerieux Takes Equity Stake in … Read the original article on Gaea Times at : bioMerieux and Biocartis Sign Strategic Partnership in Molecular Diagnostics.

Abbott Wins Two Scrip Awards Recognizing Excellence in Pharmaceutical and Biotech Industries

ABBOTT PARK, Illinois, November 5, 2010 – Scrip, a leading global pharmaceutical and biotech news organization,
honored Abbott (NYSE: ABT) with two 2010 Scrip Awards for its business
excellence and strong management.

"We are honored to receive these two prestigious awards on behalf of our
90,000 employees worldwide," said Miles D. White, chairman and …. Source  : Gaea News Network.

Serono Symposia International Foundation (SSIF) “The Biological Basis of Progressive MS”

Towards Improvement of Future Management of Progressive Forms of MS
ROME, November 5, 2010 – Some of the most experienced clinicians and scientists working
in the field of multiple sclerosis will gather in Montreal on November the
6th during the Symposium- "The biological basis of progressive MS held by
Serono Symposia International Foundation," in order to discuss the … Read more >>>.

Hoya Announces Second Quarter Financial Results

TOKYO, November 5, 2010 – HOYA Corporation today announced financial results for the second quarter
ended September 30, 2010. Net sales were up 0.2% to 107,075 million yen
year-on-year, and operating income rose 0.3% to 18,768 million yen. Net
income was up 24.5% to 12,891 million yen, and earnings per share were 29.88
yen compared with 23.91 yen [..] Read the original article: here.